Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Patrizia Caroleo"'
Autor:
Paola Quaresima, Federica Visconti, Fabiana Interlandi, Luigi Puccio, Patrizia Caroleo, Giuseppina Amendola, Michele Morelli, Roberta Venturella, Costantino Di Carlo
Publikováno v:
BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Gestational diabetes mellitus (GDM) incidence is increasing worldwide. It represents a major risk factor for adverse foetal-maternal outcomes. Awareness among women in regard to GDM-related risks (in particular foetus ones) has be
Externí odkaz:
https://doaj.org/article/dace1f10b43749da95d94a48a5d15ebf
Autor:
Paola Quaresima, Federica Visconti, Eusebio Chiefari, Maria Mirabelli, Massimo Borelli, Patrizia Caroleo, Daniela Foti, Luigi Puccio, Roberta Venturella, Costantino Di Carlo, Antonio Brunetti
Publikováno v:
Journal of Diabetes Research, Vol 2020 (2020)
Background. Screening strategies for gestational diabetes mellitus (GDM) earlier than 24-28 weeks of gestation should be considered to prevent adverse pregnancy outcomes. Nonetheless, there is uncertainty about which women would benefit most from ear
Externí odkaz:
https://doaj.org/article/999d92dcd8d247c6a5fc8f8f9e76bfd5
Autor:
Maria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, Raffaella Vero, Francesco Saverio Brunetti, Domenica Maria Corigliano, Biagio Arcidiacono, Daniela Patrizia Foti, Luigi Puccio, Antonio Brunetti
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Background. SGLT-2 (sodium-glucose cotransporter-2) inhibitors are a novel class of oral hypoglycemic agents for the management of type 2 diabetes mellitus (T2DM). Herein, we aimed to assess the long-term effectiveness and safety of SGLT-2 inhibitors
Externí odkaz:
https://doaj.org/article/faca723858df47a291516a9102faefea
Autor:
Patrizia Caroleo, Michele Morelli, Costantino Di Carlo, Fabiana Interlandi, Paola Quaresima, Giuseppina Amendola, Roberta Venturella, Federica Visconti, Luigi Puccio
Publikováno v:
BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Pregnancy and Childbirth
BMC Pregnancy and Childbirth
Background Gestational diabetes mellitus (GDM) incidence is increasing worldwide. It represents a major risk factor for adverse foetal-maternal outcomes. Awareness among women in regard to GDM-related risks (in particular foetus ones) has been proven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ed5c967c1c100fa4f20e8088c5d59d
https://doaj.org/article/dace1f10b43749da95d94a48a5d15ebf
https://doaj.org/article/dace1f10b43749da95d94a48a5d15ebf
Autor:
Daniela Foti, Vera Tocci, Emanuela Greco, Eusebio Chiefari, Stefania Giuliano, Luigi Puccio, Antonio Aversa, Antonio Brunetti, Maria Mirabelli, Raúl M. Luque, Patrizia Caroleo
Publikováno v:
Journal of Clinical Medicine 10(5), 985 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Journal of Clinical Medicine
Volume 10
Issue 5
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Journal of Clinical Medicine, Vol 10, Iss 985, p 985 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Journal of Clinical Medicine
Volume 10
Issue 5
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Journal of Clinical Medicine, Vol 10, Iss 985, p 985 (2021)
Aims and methods: The aim of this monocentric retrospective observational study was to evaluate the 18-month safety and effectiveness of GLP-1 receptor agonist (GLP-1 RA) dulaglutide (DU) 1.5 mg/once weekly as an add-on to metformin (MET) or MET plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ece648a551863b3f91599f0d37ccc01
http://hdl.handle.net/10396/21105
http://hdl.handle.net/10396/21105
Autor:
Eusebio Chiefari, Antonio Brunetti, Massimo Borelli, Daniela Foti, Maria Mirabelli, Roberta Venturella, Luigi Puccio, Costantino Di Carlo, Federica Visconti, Paola Quaresima, Patrizia Caroleo
Publikováno v:
Journal of Diabetes Research, Vol 2020 (2020)
Background. Screening strategies for gestational diabetes mellitus (GDM) earlier than 24-28 weeks of gestation should be considered to prevent adverse pregnancy outcomes. Nonetheless, there is uncertainty about which women would benefit most from ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4ecd1d95af9d5c0286142eaaa531db
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
Autor:
Antonio Brunetti, Daniela Foti, Luigi Puccio, Stefania Giuliano, Eusebio Chiefari, Francesco Saverio Brunetti, Biagio Arcidiacono, Maria Mirabelli, Patrizia Caroleo, Sinan Tanyolaç, Domenica Maria Corigliano
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 17, Iss 1, p 207 (2019)
International Journal of Environmental Research and Public Health
Volume 17
Issue 1
International Journal of Environmental Research and Public Health
Volume 17
Issue 1
Background: Liraglutide is the first glucagon-like peptide-1 receptor agonist (GLP-1 RA) based on the human GLP-1 sequence, with potential weight loss benefits, approved for the treatment of type 2 diabetes (T2D) mellitus. Herein, we aimed to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c088fc6eec5e721e09b294ce2656f7
https://doi.org/10.3390/ijerph17010207
https://doi.org/10.3390/ijerph17010207